Back to Podcasts

FDA’s approach to post-market surveillance

Episode 1 is hosted by Adarsh Thaker, MD. He is joined by Shani Haugen, PhD, who will help us understand how the FDA is addressing duodenoscope-related infection issues. They’ll answer key questions like what do FDA’s Safety Communications mean for GIs, what have we learned from 522 studies, and what do we still have to learn?